biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > August

<< Previous

Bullboard Posts

Next >>

Comment by Aarcoron Aug 04, 2022 1:41pm

129 Views

Post# 34871624

RE:RE:RE:RE:RE:RE:August

Hi JD, I hope you're feeling well today.

Great posts yesterday ! One was talking about how management doesn't have the capability to monetize xb3 and the other was about challenging why management is not in a great negotiating position to moneitize xb3. Hmmm....not sure what to make of all that.

Anyway, I gave you 100 reads and a thumbs up on each!! All of the simps weighed in on the one about the latter, but a few of them neglected to thumbs up the one about management and ice cream - you might want to talk to them about that.

Have a great day !

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute